Hälsa & medicin
4.1
Stem cell transplant patients face severe COVID-19 risk, registry study shows
A major European registry reveals that COVID-19 poses outsized danger to stem cell transplant recipients, a vulnerable population that includes cancer and blood disorder patients. The finding has implications for treatment protocols, hospital resource planning, and post-transplant care strategies in the immunocompromised population.
Originaltitel: Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry